Neudle.com: aphasia metabolic disorder causing

Differential
(Click to cross reference)

abscess, intracerebral

Addison's disease

adverse drug reaction

afebrile

agitation

alternating hemiplegia

alternating hemiplegia of childhood

aphasia, metabolic disorder causing

attention deficit disorder with hyperactivity

autism

B cell lymphoma

bacterial infection

Benedict's solution test

bifid uvula

brain biopsy

Broca's aphasia

calcification, intracranial

cardiac catheterization

cardiac catheterization, neurologic complications

CAT scan, abnormal

CAT scan, disappearing lesion on

CD19-directed chimeric antigen receptor T-cell therapy

cerebellar atrophy, secondary

cerebellar degeneration

cerebral palsy

cerebral palsy, associated problems with

cerebral palsy, pure ataxic

cerebrovascular accident

cerebrovascular accident, mimics

cerebrovascular accident, misdiagnosis

chemotherapy, CNS treatment and complications with

children

choreoathetosis

cleft palate

Clinical Pathologic Conference(C.P.C.)

confusional state, acute

contrast agent

contrast agents, neurotoxicity of

cortical blindness

creatine phosphokinase(CPK)elevated

cytokine release syndrome

delirium

dementia

dementia, rapidly progressive

differential diagnosis

dinitrophenylhydrazine(D.N.P.H.)reaction

diplegia, atonic

diplegia, spastic cerebral

disorientation

drug abuse

drug abuse, neurologic complications of

drug abuse, toxic screen In

electroencephalogram, abnormalities of

encephalitis

encephalitis, viral

encephalopathy

encephalopathy, acute

encephalopathy, metabolic

encephalopathy, progressive

eye movement, disorders of

hallucination, auditory

headache

hearing loss

hearing problems in children

hemianopia

hemianopia, transient

hemiparesis

hemiplegia

hemolytic-uremic syndrome

hepatic encephalopathy

hippocampal atrophy

hippocampus, hyperintense

human herpesvirus 6

hyperactivity

hypertension

iatrogenic neurologic disorders

imbalance

immune effector cell-associated neurotoxicity syndrome

immune-related adverse events

immunosuppression

immunosuppressive agents

immunotherapy

impulsivity

intellectual deficit

intellectual deficit, treatable causes of

intelligence quotient

karyotyping

klippel feil syndrome

lactic acidemia

language disorders in children

lethargy

leukemia

leukoencephalopathy

leukoencephalopathy, toxic

lymphoma involving CNS

lymphoma, primary of CNS

lymphoma, systemic

maple syrup urine disease

MELAS syndrome

memory, impairment of

meningitis, aseptic

mental retardation

mental status, abnormal

metabolic disorder, primary

methotrexate

microangiopathic hemolytic anemia

midline defect in children

migraine

mimics

misdiagnosis

mitochondrial disease

mitochondrial encephalomyopathy

MRI, contrast enhanced

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, negative

muscle biopsy

muscle weakness, proximal

myoclonus, stimulus sensitive

myopathy

myopathy, mitochondrial

nasal speech

negative

neoplasm, metastatic to CNS

neoplasm, metastatic to CNS-differential diagnosis of

neoplasm, primary intracerebral, presenting as CVA

neoplasm, primary of CNS

neurologic complications

neurologic complications of, systemic disease

neurologic disease, diagnoses of

neurologic examination, focal

ophthalmoplegia, progressive external

organ transplantation

palatopharyngeal incompetence

paraphasias

personality change

phenylketonuria

pleocytosis of cerebrospinal fluid

polyneuropathy

post transplant lymphoproliferative disease

prognosis

progressive neurologic disorder

proteinuria

pseudosubarachnoid hemorrhage

psychological testing, neurologic problems

psychosis

psychosis, childhood

psychosocial aspects

radiation therapy, CNS treatment and complications with

rapidly progressing neurologic illness

seizure, advice to parents and teachers regarding

seizure, psychosocial aspects of

seizure, treatment of

sensorineural hearing loss

Shiga toxin

short stature

speech disorder

speech disorder, childhood

speech, slowed

spina bifida

staphylococcal protein A column therapy

temporal lobe, lesion

temporal lobe, lesion, bilateral

thrombocytopenia

thrombotic microangiopathy

toxic encephalopathy

transient neurologic deficit

treatment of neurologic disorder

upgaze, paralysis of

urine test for metabolic disorders

urine test in toxic screen

walking, difficulty with

word-finding difficulty

Showing articles 300 to 350 of 17683 << Previous Next >>

Metabolic Disease and Stroke: MELAS
emedicine.com, Mandava,P.,et al, 2006

Clinicopath Conf, Diffuse Large B-Cell Lymphoma, EBV-Positive, with Immunosuppression
NEJM 354:1178-1184, Case 8-2006, 2006

Reversible Posterior Leukoencephalopathy Syndrome and Bevacizumab
NEJM 354:980-982, Ozcan,C.,et al, 2006

MATILDE Regimen Followed by Radiotherapy is an Active Strategy Against Primary CNS Lymphomas
Neurol 66:1435-1438, Ferreri,A.J.M.,et al, 2006

Intravascular Lymphoma: The Oncologists "Great Imitator"
The Oncologist 11:496-502, Zuckerman, D.,et al, 2006

Diffusion-Weighted Cranial MR Imaging Findings in a Patient with Hemophagocytic Syndrome
AJNR 27:1312-1314, Ozgen, B.,et al, 2006

Sensorineural Hearing Loss After Radiotherapy and Chemoradiotherapy: A Single, Blinded, Randomized Study
J Clin Oncol 24:1904-1909, Low, W.K.,et al, 2006

Clinicopath Conf., MELAS Syndrome
NEJM 353:2271-2280, Case 36-2005, 2005

Neurologic Manifestations in Welders with Pallidal MRI T1 Hyperintensity
Neurol 64:2033-2039,2001, Josephs,K.A.,et al, 2005

Diffusion-Weighted MR Imaging of Early Methotrexate-Related Neurotoxicity in Children
AJNR 26:1686-1689, Fisher,M.J.,et al, 2005

Malignant Hyperthermia, Update on Susceptibility Testing
JAMA 293:2918-2924,2958, Litman,R.S.&Rosenberg,H., 2005

Rehabilitation After Stroke
NEJM 352:1677-1684, Dobkin,B.H., 2005

NOA-03 Trial of High-Dose Methotrexate in Primary Central Nervous System Lymphoma:Final Report
Ann Neurol 57:843-847, Herrlinger,W.,et al, 2005

Association of the Metabolic Syndrome with Intracranial Atherosclerotic Stroke
Neurol 65:296-298,188, Bang,O.Y.,et al, 2005

Delayed Neurotoxicity in Primary Central Nervous System Lymphoma
Arch Neurol 62:1595-1600, Omuro,A.M.P.,et al, 2005

Capecitabine-Induced Multifocal Leukoencephalopathy: A Report of Five Cases
Neurol 65:1792-1794, Videnovic,A.,et al, 2005

Clinicopath Conf., Primary Diffuse Large-B-Cell Lymphoma of the Brain
NEJM 352:185-194, Case 1-2005, 2005

Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
NEJM 352:987-996, 1036, Stupp,R., et al, 2005

MGMT Gene Silencing and Benefit From Temozolomide in Glioblastoma
NEJM 352:997-1003, 1036, Hegi,M.E., et al, 2005

Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy Alone
NEJM 352:10 978-986, 1036, Rutkowski,S., et al, 2005

Patterns of Care for Adults With Newly Diagnosed Malignant Glioma
JAMA 293:557-564,615, Chang,S.M.,et al, 2005

Methyl Bromide Intoxication Causes Reversible Symmetric Branstem and Cerebellar MRI Lesions
Neurol 64:1279-1281, Geyer,H.L.,et al, 2005

Neuropathy Resembling CIDP in Patients Receiving Tumor Necrosis Factor-a Blockers
Neurol 64:1468-1470, Richez,C.,et al, 2005

Cerebral MR Imaging in Uninfected Children Born to HIV-Seropositive Mothers and Perinatally Exposed to Zidovudine
AJNR 26:695-701,687, Tardieu,M.,et al, 2005

Prevalence of Leukoencephalopathy in Children Treated for Acute Lymphoblastic Leukemia with High-Dose Methotrexate
AJNR 26:1263-1269, Reddick,W.E.,et al, 2005

Leukoencephalopathy From "Chasing the Dragon"
Neurol 64:1755, Halloran,O.,et al, 2005

Reversible Posterior Leukoencephalopathy Syndrome
Intern Med J 35:83-90, Stott,V.L.,et al, 2005

Update on Primary Central Nervous System Lymphoma
Curr Opin Neurol 18:645-653, Plotkin,S.R., 2005

Chasing "Chasing the Dragon" with MRI: Leukoencephalopathy in Drug Abuse
Br J Radiol 78:997-1004, Bartlett,E. &Mikulis,D.J., 2005

Diffusion-Weighted Imaging and Proton MR Spectroscopy of White Matter Abnormalities in a Case of Phenylketonuria
Eur J Radiol Extra 54: 5-9, Teksam,M.,et al., 2005

Treatment-Induced Leukoencephalopathy in Primary CNS Lymphoma,A Clinical and Autopsy Study
Neurol 62:451-456, Lai,R.,et al, 2004

Clinical and MRI Outcome after Autologous Hematoipoietic Stem Cell Transplantation in MS
Neurol 62:282-284,168, Saiz,A.,et al, 2004

Therapy for Nerve Agent Poisoning
Arch Neurol 61:649-652, Newmark,J., 2004

Aromatic L-Amino Acid Decarboxylase Deficiency
Neurol 62:1058-1065, Pons,R.,et al, 2004

Cognitive Functions in Survivors of Primary Central Nervous System Lymphoma
Neurol 62:548-555,532, Correa,D.D.,et al, 2004

Cognitive Status and Quality of Life After Treatment for Primary CNS Lymphoma
Neurol 62:544-547,532, Harder,H.,et al, 2004

Recurrent Acroparaesthesia During Febrile Infections
Lancet 363:1698, Bodamer,O.A.,et al, 2004

Initial Chemotherapy in Gliomatosis Cerebri
Neurol 63:270-275,204, Sanson,M.,et al, 2004

Peripheral Neuropathy
Lancet 363:2151-2161, England,J.D. &Asbury,A.K., 2004

Thalidomide Sensory Neurotoxicity
Neurol 62:2291-2293, Cavaletti,G.,et al, 2004

Chemotherapy as Initial Treatment in Gliomatosis Cerebri
Neurol 63:354-356, Levin,N.,et al, 2004

Clinicopath Conf, Anaplastic Oligodendroglioma with Allelic Loss of Chromosomes 1p and 19q
NEJM 351:1875-1882, Case 33-2004, 2004

Tacrolimus Leukoencephalopathy: A Neuropathologic Confirmation
Neurol 63:1132-1133, Lavigne,C.M.,et al, 2004

Genetic, Clinical, and Radiographic Delineation of Hallervorden-Spatz Syndrome
NEJM 348:33-40, Hayflick,S.J.,et al, 2003

Neurological Aspects of Biological and Chemical Terrorism
Arch Neurol 60:21-25, Martin,C.O., &Adams,H.P., 2003

Primary Brain Tumours in Adults
Lancet 361:323-331, Behin,A.,et al, 2003

Practice Parameter: Evaluation of the Child with Global Developmental Delay
Neurol 60:367-380, Shevell,M.,et al, 2003

Neonatal Epileptic Encephalopathy
Lancet 361:1614, Clayton,P.T.,et al, 2003

Clinical Spectrum of Succinic Semialdehyde Dehydrogenase Deficiency
Neurol 60:1413-1417, Pearl,P.L.,et al, 2003

Mitochondrial Respiratory-Chain Diseases
NEJM 348:2656-2668, DiMauro,S. &Schon,E.A., 2003

Showing articles 300 to 350 of 17683 << Previous Next >>